Design Therapeutics, Inc.
DSGN • NASDAQ
Design Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Pratik Shah, with a market cap of $649.4M.
CEOPratik Shah
Next Earnings
Upcoming earnings announcement for Design Therapeutics, Inc.
Date
Wednesday, May 6, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.34
Earnings History
Past 12 earnings reports for Design Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 9, 2026 | Q4 2025 | -$0.27Est: -$0.36 | +25.0% | - | — |  10-K |
| Nov 5, 2025 | Q3 2025 | -$0.30Est: -$0.34 | +11.8% | - | — | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.34Est: -$0.33 | -3.0% | - | — | 10-Q |
| May 7, 2025 | Q1 2025 | -$0.31Est: -$0.28 | -10.7% | - | — | 10-Q |
| Mar 10, 2025 | Q4 2024 | -$0.24Est: -$0.27 | +11.1% | - | — | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.23Est: -$0.24 | +4.2% | - | — | 10-Q |
| Aug 5, 2024 | Q2 2024 | -$0.21Est: -$0.23 | +8.7% | - | — | 10-Q |
| May 8, 2024 | Q1 2024 | -$0.20Est: -$0.29 | +31.0% | - | — | 10-Q |
| Mar 19, 2024 | Q4 2023 | -$0.21Est: -$0.31 | +32.3% | - | — | 10-K |
| Nov 13, 2023 | Q3 2023 | -$0.28Est: -$0.41 | +31.7% | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$0.36Est: -$0.40 | +10.0% | - | — | 10-Q |
| May 9, 2023 | Q1 2023 | -$0.35Est: -$0.36 | +2.8% | - | — | — |